4502 — Takeda Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥6tn
- ¥11tn
- ¥4tn
- 30
- 57
- 44
- 37
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 109,014 | 44,290 | 376,171 | 230,166 | 317,038 |
Depreciation | |||||
Non-Cash Items | 39,061 | 172,928 | 12,308 | 252,109 | 327,626 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -92,220 | -130,486 | 62,781 | 57,679 | -331,908 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 328,301 | 670,381 | 1,010,931 | 1,123,105 | 977,156 |
Capital Expenditures | -134,114 | -217,710 | -236,468 | -186,037 | -633,689 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -2,701,584 | 509,829 | 629,998 | -12,088 | 26,587 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,835,698 | 292,119 | 393,530 | -198,125 | -607,102 |
Financing Cash Flow Items | -71,143 | -132,804 | -142,352 | -108,592 | -117,732 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2,946,237 | -1,005,213 | -1,088,354 | -1,070,265 | -709,148 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 407,571 | -64,479 | 328,608 | -116,527 | -316,165 |